Brief: Hemogenyx Pharmaceuticals Says DSMB Clears Next Dose Level Of HG-CT-1, Opens Pediatric Recruitment
Oct 29 (Reuters) - Hemogenyx Pharmaceuticals PLC HEMO.L: HEMOGENYX PHARMA PLC - CLINICAL TRIAL UPDATE AND GRANT OF SHARE AWARDS HEMOGENYX PHARMACEUTICALS PLC - DSMB CLEARS NEXT DOSE LEVEL OF HG-CT-1, OPENS PEDIATRIC RECRUITMENT Source text: ID:nRSc1973Fa Further company coverage: HEMO.L ((Reuters.Briefs@thomsonreuters.com;))